GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000003 | Reproduction |
| Process | GO:0001701 | In utero embryonic development |
| Process | GO:0001890 | Placenta development |
| Process | GO:0001892 | Embryonic placenta development |
| Process | GO:0002250 | Adaptive immune response |
| Process | GO:0002376 | Immune system process |
| Process | GO:0003006 | Developmental process involved in reproduction |
| Process | GO:0006355 | Regulation of transcription, DNA-templated |
| Process | GO:0006357 | Regulation of transcription by RNA polymerase II |
| Process | GO:0006914 | Autophagy |
| Process | GO:0006950 | Response to stress |
| Process | GO:0006952 | Defense response |
| Process | GO:0006955 | Immune response |
| Process | GO:0006959 | Humoral immune response |
| Process | GO:0006996 | Organelle organization |
| Process | GO:0007033 | Vacuole organization |
| Process | GO:0007040 | Lysosome organization |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0009056 | Catabolic process |
| Process | GO:0009267 | Cellular response to starvation |
| Process | GO:0009605 | Response to external stimulus |
| Process | GO:0009607 | Response to biotic stimulus |
| Process | GO:0009617 | Response to bacterium |
| Process | GO:0009790 | Embryo development |
| Process | GO:0009792 | Embryo development ending in birth or egg hatching |
| Process | GO:0009889 | Regulation of biosynthetic process |
| Process | GO:0009891 | Positive regulation of biosynthetic process |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009894 | Regulation of catabolic process |
| Process | GO:0009896 | Positive regulation of catabolic process |
| Process | GO:0009987 | Cellular process |
| Process | GO:0009991 | Response to extracellular stimulus |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010506 | Regulation of autophagy |
| Process | GO:0010508 | Positive regulation of autophagy |
| Process | GO:0010556 | Regulation of macromolecule biosynthetic process |
| Process | GO:0010557 | Positive regulation of macromolecule biosynthetic process |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0019219 | Regulation of nucleobase-containing compound metabolic process |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0022414 | Reproductive process |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031325 | Positive regulation of cellular metabolic process |
| Process | GO:0031326 | Regulation of cellular biosynthetic process |
| Process | GO:0031328 | Positive regulation of cellular biosynthetic process |
| Process | GO:0031329 | Regulation of cellular catabolic process |
| Process | GO:0031331 | Positive regulation of cellular catabolic process |
| Process | GO:0031667 | Response to nutrient levels |
| Process | GO:0031668 | Cellular response to extracellular stimulus |
| Process | GO:0031669 | Cellular response to nutrient levels |
| Process | GO:0032418 | Lysosome localization |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0033554 | Cellular response to stress |
| Process | GO:0034198 | Cellular response to amino acid starvation |
| Process | GO:0042594 | Response to starvation |
| Process | GO:0042742 | Defense response to bacterium |
| Process | GO:0043009 | Chordate embryonic development |
| Process | GO:0043207 | Response to external biotic stimulus |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044248 | Cellular catabolic process |
| Process | GO:0044419 | Biological process involved in interspecies interaction between organisms |
| Process | GO:0045893 | Positive regulation of transcription, DNA-templated |
| Process | GO:0045935 | Positive regulation of nucleobase-containing compound metabolic process |
| Process | GO:0045944 | Positive regulation of transcription by RNA polymerase II |
| Process | GO:0048513 | Animal organ development |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048568 | Embryonic organ development |
| Process | GO:0048608 | Reproductive structure development |
| Process | GO:0048731 | System development |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050829 | Defense response to Gram-negative bacterium |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051173 | Positive regulation of nitrogen compound metabolic process |
| Process | GO:0051179 | Localization |
| Process | GO:0051252 | Regulation of RNA metabolic process |
| Process | GO:0051254 | Positive regulation of RNA metabolic process |
| Process | GO:0051640 | Organelle localization |
| Process | GO:0051707 | Response to other organism |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0061458 | Reproductive system development |
| Process | GO:0061919 | Process utilizing autophagic mechanism |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0071496 | Cellular response to external stimulus |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:0080171 | Lytic vacuole organization |
| Process | GO:0098542 | Defense response to other organism |
| Process | GO:1902680 | Positive regulation of RNA biosynthetic process |
| Process | GO:1903506 | Regulation of nucleic acid-templated transcription |
| Process | GO:1903508 | Positive regulation of nucleic acid-templated transcription |
| Process | GO:1990849 | Vacuolar localization |
| Process | GO:1990928 | Response to amino acid starvation |
| Process | GO:2001141 | Regulation of RNA biosynthetic process |
| Component | GO:0000323 | Lytic vacuole |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005634 | Nucleus |
| Component | GO:0005667 | Transcription regulator complex |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005764 | Lysosome |
| Component | GO:0005765 | Lysosomal membrane |
| Component | GO:0005773 | Vacuole |
| Component | GO:0005774 | Vacuolar membrane |
| Component | GO:0005829 | Cytosol |
| Component | GO:0016020 | Membrane |
| Component | GO:0031090 | Organelle membrane |
| Component | GO:0032991 | Protein-containing complex |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0098588 | Bounding membrane of organelle |
| Component | GO:0098852 | Lytic vacuole membrane |
| Component | GO:0110165 | Cellular anatomical entity |
| Function | GO:0000976 | Transcription cis-regulatory region binding |
| Function | GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| Function | GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| Function | GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Function | GO:0000987 | Cis-regulatory region sequence-specific DNA binding |
| Function | GO:0001067 | Transcription regulatory region nucleic acid binding |
| Function | GO:0001216 | DNA-binding transcription activator activity |
| Function | GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific |
| Function | GO:0003676 | Nucleic acid binding |
| Function | GO:0003677 | DNA binding |
| Function | GO:0003690 | Double-stranded DNA binding |
| Function | GO:0003700 | DNA-binding transcription factor activity |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0019899 | Enzyme binding |
| Function | GO:0043565 | Sequence-specific DNA binding |
| Function | GO:0046982 | Protein heterodimerization activity |
| Function | GO:0046983 | Protein dimerization activity |
| Function | GO:0097159 | Organic cyclic compound binding |
| Function | GO:0140110 | Transcription regulator activity |
| Function | GO:1901363 | Heterocyclic compound binding |
| Function | GO:1990837 | Sequence-specific double-stranded DNA binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| WikiPathways | WP1763 | Mechanisms associated with pluripotency |
| WikiPathways | WP4763 | Regulation of Pgc1a expression by a Gsk3b-Tfeb signaling axis in skeletal muscle |
| KEGG | mmu04020 | Calcium signaling pathway |
| KEGG | mmu04137 | Mitophagy - animal |
Expression profile of Tfeb in omics data
| ID | GSE106799 |
| Title | Propofol alters the mRNA profile in the developing mouse hippocampus |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2850452 | Control 1 | tissue: hippocampus age: 7 days-old | 8.0799048 |
| GSM2850453 | Control 2 | tissue: hippocampus age: 7 days-old | 7.6680022 |
| GSM2850454 | Control 3 | tissue: hippocampus age: 7 days-old | 7.910948250000001 |
| GSM2850455 | Control 4 | tissue: hippocampus age: 7 days-old | 8.01497175 |
| GSM2850456 | Propofol 1 | tissue: hippocampus age: 7 days-old | 7.1418165 |
| GSM2850457 | Propofol 2 | tissue: hippocampus age: 7 days-old | 7.9680675 |
| GSM2850458 | Propofol 3 | tissue: hippocampus age: 7 days-old | 7.9820775 |
| GSM2850459 | Propofol 4 | tissue: hippocampus age: 7 days-old | 7.3985331500000004 |
| ID | GSE109165 |
| Title | Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2934457 | WT_Naive_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 331.0 |
| GSM2934458 | WT_Naive_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 660.0 |
| GSM2934459 | WT_Naive_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 647.0 |
| GSM2934460 | WT_Naive_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 502.0 |
| GSM2934461 | KO_Naive_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 735.0 |
| GSM2934462 | KO_Naive_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 649.0 |
| GSM2934463 | KO_Naive_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 382.0 |
| GSM2934464 | KO_Naive_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 687.0 |
| GSM2934465 | WT_Morphine_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 357.0 |
| GSM2934466 | WT_Morphine_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 318.0 |
| GSM2934467 | WT_Morphine_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 548.0 |
| GSM2934468 | WT_Morphine_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 404.0 |
| GSM2934469 | KO_Morphine_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 301.0 |
| GSM2934470 | KO_Morphine_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 188.0 |
| GSM2934471 | KO_Morphine_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 239.0 |
| GSM2934472 | KO_Morphine_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 383.0 |
| ID | GSE125076 |
| Title | A mouse model of acute post-surgical pain |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM3562188 | DRG_WT_sham_1 | strain: C57BL/6 gender: male age: 8 weeks treatment: naïve | 214.0 |
| GSM3562189 | DRG_WT_sham_2 | strain: C57BL/6 gender: male age: 8 weeks treatment: naïve | 142.0 |
| GSM3562190 | DRG_WT_sham_3 | strain: C57BL/6 gender: male age: 8 weeks treatment: naïve | 263.0 |
| GSM3562191 | DRG_WT_PSP_1 | strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery | 307.0 |
| GSM3562192 | DRG_WT_PSP_2 | strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery | 267.0 |
| GSM3562193 | DRG_WT_PSP_3 | strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery | 261.0 |
| ID | GSE126662 |
| Title | Comparison between opioid (morphine) and vehicle treatments in mouse trigeminal ganglia and nucleus accumbens |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM3610703 | TG_M1: OIH_M1_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 127.14290229946572 |
| GSM3610704 | TG_M2: OIH_M2_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 96.71428428571429 |
| GSM3610705 | TG_M3: OIH_M3_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 104.42852857142857 |
| GSM3610706 | TG_M4: OIH_M4_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 116.85709971428572 |
| GSM3610707 | TG_M5: OIH_M5_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 91.85709857142857 |
| GSM3610708 | TG_V1: VehicleOIH_V1_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 88.85716002000001 |
| GSM3610709 | TG_V2: VehicleOIH_V2_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 116.14284571602936 |
| GSM3610710 | TG_V3: VehicleOIH_V3_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 109.57151285714285 |
| GSM3610711 | TG_V4: VehicleOIH_V4_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 99.99999428571428 |
| GSM3610712 | TG_V5: VehicleOIH_V5_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 115.57132014285715 |
| GSM3610713 | NAc_M1: OIH_M1_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 48.42856714285715 |
| GSM3610714 | NAc_M2: OIH_M2_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 44.857079999999996 |
| GSM3610715 | NAc_M3: OIH_M3_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 50.42849285714285 |
| GSM3610716 | NAc_M4: OIH_M4_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 49.714301428571424 |
| GSM3610717 | NAc_M5: OIH_M5_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 51.00008571428572 |
| GSM3610718 | NAc_V1: VehicleOIH_V1_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 54.42862 |
| GSM3610719 | NAc_V2: VehicleOIH_V2_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 57.71421844 |
| GSM3610720 | NAc_V3: VehicleOIH_V3_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 44.85711714285714 |
| GSM3610721 | NAc_V4: VehicleOIH_V4_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 57.28577142857143 |
| GSM3610722 | NAc_V5: VehicleOIH_V5_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 51.571490037871435 |
| ID | GSE138802 |
| Title | Mesocorticolimbic circuit mechanisms underlying the effects of ketamine on dopamine: a translational imaging study |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4119733 | PLc_1_Sal | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Saline | 172.42 |
| GSM4119734 | PLc_10_Sal | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Saline | 340.42 |
| GSM4119735 | PLc_6_Sal | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Saline | 160.21 |
| GSM4119736 | PLc_5_Ket | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Ketamine | 199.44 |
| GSM4119737 | PLc_3_Ket | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Ketamine | 265.27 |
| GSM4119738 | PLc_9_Ket | strain: C57Bl/6 age: 9 weeks tissue: Pre-limbic cortex treatment: Ketamine | 259.24 |
| ID | GSE163828 |
| Title | Regulation of electro-acupuncture(EA) and astragalus membranaceus (AM) on genes in bone marrow |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4988039 | BH190126-1_control | tissue: bone marrow | 5.68 |
| GSM4988040 | BH190126-1_treatment of astragalus membranaceus | tissue: bone marrow | 5.64 |
| GSM4988041 | BH190126-1_cisplatin | tissue: bone marrow | 5.71 |
| GSM4988042 | BH190126-1_treatment of electro-acupuncture | tissue: bone marrow | 5.68 |
| ID | GSE20160 |
| Title | Gene Expression Data from Prefrontal Cortex and Nucleus Accumbens from Inbred Strains of Mice |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM505749 | 129S1/SvImJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: 129S1/SvImJ | 24.56 |
| GSM505750 | A/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: A/J | 24.148 |
| GSM505751 | AKR/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: AKR/J | 24.522 |
| GSM505752 | BALB/cByJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: BALB/cByJ | 24.849 |
| GSM505753 | BTBR_T+_tf/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: BTBR_T+_tf/J | 24.65 |
| GSM505754 | BUB/BnJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: BUB/BnJ | 24.714 |
| GSM505755 | C3H/HeJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C3H/HeJ | 24.349 |
| GSM505756 | C57BL/6J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C57BL/6J | 24.957 |
| GSM505757 | C57BR/cdJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C57BR/cdJ | 24.763 |
| GSM505758 | C58/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C58/J | 24.826 |
| GSM505759 | CBA/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: CBA/J | 24.844 |
| GSM505760 | CE/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: CE/J | 25.142 |
| GSM505761 | DBA/2J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: DBA/2J | 22.944 |
| GSM505762 | FVB/NJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: FVB/NJ | 27.23 |
| GSM505763 | I/LnJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: I/LnJ | 26.497 |
| GSM505764 | KK/HlJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: KK/HlJ | 24.735 |
| GSM505765 | MA/MyJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: MA/MyJ | 24.71 |
| GSM505766 | MRL_MpJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: MRL/MpJ | 24.369 |
| GSM505767 | NOD/LtJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NOD/LtJ | 24.556 |
| GSM505768 | NON/LtJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NON/LtJ | 27.133 |
| GSM505769 | NZO/HILtJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NZO/HILtJ | 24.842 |
| GSM505770 | NZW_LacJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NZW_LacJ | 21.571 |
| GSM505771 | P/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: P/J | 29.015 |
| GSM505772 | PL/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: PL/J | 25.222 |
| GSM505773 | RIIIS/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: RIIIS/J | 24.915 |
| GSM505774 | SJL/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: SJL/J | 24.862 |
| GSM505775 | SM/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: SM/J | 26.474 |
| GSM505776 | SWR/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: SWR/J | 24.912 |
| GSM505777 | WSB/EiJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: WSB/EiJ | 27.918 |
| GSM505778 | 129S1/SvImJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: 129S1/SvImJ | 36.878 |
| GSM505779 | A/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: A/J | 37.761 |
| GSM505780 | AKR/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: AKR/J | 42.09 |
| GSM505781 | BALB/cByJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: BALB/cByJ | 41.149 |
| GSM505782 | BTBR_T+_tf/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: BTBR_T+_tf/J | 42.12 |
| GSM505783 | BUB/BnJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: BUB/BnJ | 46.183 |
| GSM505784 | C3H/HeJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C3H/HeJ | 36.799 |
| GSM505785 | C57BL/6J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C57BL/6J | 37.235 |
| GSM505786 | C57BR/cdJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C57BR/cdJ | 37.3 |
| GSM505787 | C58/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C58/J | 37.217 |
| GSM505788 | CBA/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: CBA/J | 38.778 |
| GSM505789 | CE/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: CE/J | 38.808 |
| GSM505790 | DBA/2J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: DBA/2J | 36.702 |
| GSM505791 | FVB/NJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: FVB/NJ | 39.151 |
| GSM505792 | I/LnJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: I/LnJ | 37.188 |
| GSM505793 | KK/HlJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: KK/HlJ | 36.948 |
| GSM505794 | MA/MyJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: MA/MyJ | 37.314 |
| GSM505795 | NOD/LtJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: NOD/LtJ | 34.005 |
| GSM505796 | NON/LtJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: NON/LtJ | 37.384 |
| GSM505797 | NZW/LacJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: NZW/LacJ | 37.188 |
| GSM505798 | P/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: P/J | 34.829 |
| GSM505799 | PL/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: PL/J | 36.287 |
| GSM505800 | RIIIS/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: RIIIS/J | 31.014 |
| GSM505801 | SJL/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: SJL/J | 37.411 |
| GSM505802 | SM/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: SM/J | 34.382 |
| GSM505803 | SWR/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: SWR/J | 34.466 |
| GSM505804 | WSB/EiJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: WSB/EiJ | 37.643 |
| ID | GSE205201 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [mouse] |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208462 | Mouse_Baseline_0h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.413379 |
| GSM6208463 | Mouse_Baseline_0h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.395652 |
| GSM6208464 | Mouse_Baseline_0h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.396599 |
| GSM6208465 | Mouse_Baseline_0h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.253786 |
| GSM6208466 | Mouse_Baseline_0h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.406915 |
| GSM6208467 | Mouse_Vehicle_03h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.234296 |
| GSM6208468 | Mouse_Vehicle_03h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.258132 |
| GSM6208469 | Mouse_Vehicle_03h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.381339 |
| GSM6208470 | Mouse_Vehicle_03h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.238866 |
| GSM6208471 | Mouse_Vehicle_03h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.449471 |
| GSM6208472 | Mouse_Vehicle_06h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.19449 |
| GSM6208473 | Mouse_Vehicle_06h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.262967 |
| GSM6208474 | Mouse_Vehicle_06h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.35301 |
| GSM6208475 | Mouse_Vehicle_06h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.173033 |
| GSM6208476 | Mouse_Vehicle_06h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.233678 |
| GSM6208477 | Mouse_Vehicle_09h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 9.307464 |
| GSM6208478 | Mouse_Vehicle_09h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 9.262967 |
| GSM6208479 | Mouse_Vehicle_09h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 9.361614 |
| GSM6208480 | Mouse_Vehicle_09h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 9.309658 |
| GSM6208481 | Mouse_Vehicle_09h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 9.212267 |
| GSM6208482 | Mouse_Vehicle_24h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 9.305011 |
| GSM6208483 | Mouse_Vehicle_24h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 9.257225 |
| GSM6208484 | Mouse_Vehicle_24h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 9.258592 |
| GSM6208485 | Mouse_Vehicle_24h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 9.232543 |
| GSM6208486 | Mouse_Vehicle_24h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 9.258035 |
| GSM6208487 | Mouse_APAP_03h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.27483 |
| GSM6208488 | Mouse_APAP_03h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.304662 |
| GSM6208489 | Mouse_APAP_03h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.351504 |
| GSM6208490 | Mouse_APAP_03h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.403354 |
| GSM6208491 | Mouse_APAP_03h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.105484 |
| GSM6208492 | Mouse_APAP_06h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 9.119405 |
| GSM6208493 | Mouse_APAP_06h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 9.230733 |
| GSM6208494 | Mouse_APAP_06h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 9.317799 |
| GSM6208495 | Mouse_APAP_06h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 8.947167 |
| GSM6208496 | Mouse_APAP_06h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 9.213362 |
| GSM6208497 | Mouse_APAP_09h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.354906 |
| GSM6208498 | Mouse_APAP_09h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.279041 |
| GSM6208499 | Mouse_APAP_09h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.303216 |
| GSM6208500 | Mouse_APAP_09h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.267037 |
| GSM6208501 | Mouse_APAP_09h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.191278 |
| GSM6208502 | Mouse_APAP_24h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.305148 |
| GSM6208503 | Mouse_APAP_24h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.156709 |
| GSM6208504 | Mouse_APAP_24h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.238862 |
| GSM6208505 | Mouse_APAP_24h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.31043 |
| GSM6208506 | Mouse_APAP_24h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.198158 |
| ID | GSE223541 |
| Title | Oxycodone withdrawal induces HDAC1/2-dependent transcriptional maladaptations in the reward pathway in a murine model of peripheral nerve injury |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6958536 | B1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sa | 99.0 |
| GSM6958537 | C1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 102.0 |
| GSM6958538 | F1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 32.0 |
| GSM6958539 | H1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 204.0 |
| GSM6958540 | B2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal | 170.0 |
| GSM6958541 | C2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 105.0 |
| GSM6958542 | F2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 238.0 |
| GSM6958543 | H2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 78.0 |
| GSM6958544 | B3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal | 144.0 |
| GSM6958545 | C3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 184.0 |
| GSM6958546 | F3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 13.0 |
| GSM6958547 | H3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 146.0 |
| GSM6958548 | B4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal | 156.0 |
| GSM6958549 | C4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 89.0 |
| GSM6958550 | F4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 67.0 |
| GSM6958551 | H4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 138.0 |
| ID | GSE24829 |
| Title | Gene expression data from striatal regions of MPTP-intoxicated mouse brain by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM611081 | Control mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 6.40205 |
| GSM611082 | Control mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 6.26848 |
| GSM611083 | MPTP-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 6.87208 |
| GSM611084 | MPTP-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 6.37955 |
| GSM611085 | MPTP and acupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 6.29077 |
| GSM611086 | MPTP and acupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 6.61655 |
| GSM611087 | MPTP and nonacupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 6.46031 |
| GSM611088 | MPTP and nonacupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 6.30386 |
| ID | GSE24830 |
| Title | Gene expression data from cervical spinal cord regions of MPTP-intoxicated mouse by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM611089 | Control mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 6.33005 |
| GSM611090 | Control mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 6.2514 |
| GSM611091 | MPTP-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 6.32756 |
| GSM611092 | MPTP-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 6.29535 |
| GSM611093 | MPTP and acupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 6.42843 |
| GSM611094 | MPTP and acupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 6.25675 |
| GSM611095 | MPTP and nonacupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 6.56664 |
| GSM611096 | MPTP and nonacupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 6.37208 |
| ID | GSE24838 |
| Title | Gene expression data from brain striatal and spinal cord regions of MPTP-intoxicated mouse following acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM611081 | Control mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 6.40205 |
| GSM611082 | Control mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 6.26848 |
| GSM611083 | MPTP-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 6.87208 |
| GSM611084 | MPTP-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 6.37955 |
| GSM611085 | MPTP and acupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 6.29077 |
| GSM611086 | MPTP and acupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 6.61655 |
| GSM611087 | MPTP and nonacupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 6.46031 |
| GSM611088 | MPTP and nonacupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 6.30386 |
| GSM611089 | Control mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 6.33005 |
| GSM611090 | Control mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 6.2514 |
| GSM611091 | MPTP-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 6.32756 |
| GSM611092 | MPTP-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 6.29535 |
| GSM611093 | MPTP and acupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 6.42843 |
| GSM611094 | MPTP and acupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 6.25675 |
| GSM611095 | MPTP and nonacupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 6.56664 |
| GSM611096 | MPTP and nonacupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 6.37208 |
| ID | GSE26364 |
| Title | Gene expression changes in alpha GABA receptors in the mice brains after prolonged ketamine administration |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM647254 | Saline PFC 1 | strain: ICR tissue: prefrontal cortex Sex: female | 5.38716 |
| GSM647255 | Saline PFC 2 | strain: ICR tissue: prefrontal cortex Sex: female | 5.23112 |
| GSM647256 | Ketamine PFC 1 | strain: ICR tissue: prefrontal cortex Sex: female | 5.72658 |
| GSM647257 | Ketamine PFC 2 | strain: ICR tissue: prefrontal cortex Sex: female | 5.78712 |
| ID | GSE35138 |
| Title | Gene expression data from thalamic regions of MPTP-intoxicated mouse brain by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM862520 | Control mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 6.58373 |
| GSM862521 | Control mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 6.57515 |
| GSM862522 | MPTP-treated mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 6.24026 |
| GSM862523 | MPTP-treated mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 6.65358 |
| GSM862524 | MPTP and acupoints acupuncture-treated mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 6.55922 |
| GSM862525 | MPTP and acupoints acupuncture-treated mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 6.64015 |
| GSM862526 | MPTP and nonacupoints acupuncture-treated mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 6.60951 |
| GSM862527 | MPTP and nonacupoints acupuncture-treated mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 6.56958 |
| ID | GSE48293 |
| Title | Gene expression data from substantia nigral regions of MPTP-intoxicated mouse brain by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1174263 | Control mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: Control | 1.47022 |
| GSM1174264 | Control mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: Control | 2.02849 |
| GSM1174265 | MPTP-treated mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP-treated | 2.65051 |
| GSM1174266 | MPTP-treated mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP-treated | 2.61222 |
| GSM1174267 | MPTP and acupoints acupuncture-treated mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 2.51202 |
| GSM1174268 | MPTP and acupoints acupuncture-treated mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 2.61938 |
| GSM1174269 | MPTP and nonacupoints acupuncture-treated mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 2.29794 |
| GSM1174270 | MPTP and nonacupoints acupuncture-treated mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 2.58294 |
| ID | GSE6479 |
| Title | Analgesia of naloxone and morphine in wild-type and NY1DD sickle cell mice using BMAP cDNA microarrays |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM141569 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. SCNLX-I 817 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.1791425 |
| GSM142384 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. 819 SCNLX2 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.46944693 |
| GSM142385 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. 825 SCNLX3 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.31334352 |
| GSM142386 | NY1DD Sickle Cell Mouse brains, MOR treated, 10mins. 819 SCMOR1 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.; Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.01807691 |
| GSM142387 | NY1DD Sickle Cell Mouse brains, MOR treated, 10mins. 823 SCMOR2 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.07012137 |
| GSM142388 | NY1DD Sickle Cell Mouse brains, MOR treated, 10mins. 825 SCMOR3 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.048707616 |
| GSM148906 | C57BL/6J wild-type mouse brains, MOR treated, 10mins. 916 WTMOR 1 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.086970456 |
| GSM148908 | C57BL/6J wild-type mouse brains, MOR treated, 10mins. 916 WTMOR 2 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.2776017 |
| GSM148910 | C57BL/6J wild-type mouse brains, MOR treated, 10mins. 925 WTMOR3 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.23949136 |
| GSM149076 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 915 WTNLX 1 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.35359585 |
| GSM149078 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 915 WTNLX 2 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.13717869 |
| GSM149084 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 921 WTNLX 3 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.10583445 |
| ID | GSE6578 |
| Title | Analgesia of naloxone in wild-type and NY1DD transgenic mouse model of sickle cell anemia using BMAP cDNA microarrays |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM141569 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. SCNLX-I 817 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.; Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.1791425 |
| GSM142384 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. 819 SCNLX2 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.46944693 |
| GSM142385 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. 825 SCNLX3 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.31334352 |
| GSM149076 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 915 WTNLX 1 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.35359585 |
| GSM149078 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 915 WTNLX 2 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.13717869 |
| GSM149084 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 921 WTNLX 3 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.10583445 |
